Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF292 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | EXOSC8 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ZNF197 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | NCBP2L | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | OR10Q1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | NUP54 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | NANS | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | LPL | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | SLC11A2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ZNF654 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |